{"id":"doi:10.1056/nejmoa2403347","kind":"article","title":"Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes","authors":["Vlado Perkovic","Katherine R. Tuttle","Peter R Rossing","Kenneth W. Mahaffey","Johannes F.E. Mann","George L. Bakris","Florian M.M. Baeres","Thomas Idorn","Heidrun Bosch‐Traberg","Nanna Leonora Lausvig","Richard E. Pratley"],"author_count":11,"year":2024,"published":"2024-05-24","venue":"New England Journal of Medicine","cited_by":1931,"doi":"10.1056/nejmoa2403347","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1056/nejmoa2403347","archive_url":"https://space-kitty.com/papers/doi:10.1056/nejmoa2403347","updated":null,"pmid":"38785209","pmcid":null,"openalex_id":"W4398781461","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"retracted":false,"peer_reviewed":null,"categories":["Chronic Kidney Disease and Diabetes"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[{"slug":"glp1-metabolic","title":"GLP-1 & Incretin Therapies: State of the Field (October 2026)","url":"https://space-kitty.com/dossiers/glp1-metabolic"}]}